Ovarian Cancer

我们是谁

  • 7 月 29, 2024
    A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
  • 6 月 28, 2024
    Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
  • 4 月 24, 2024
    A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
  • 2 月 5, 2024
    ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (AMPLIFY-201)
  • 7 月 24, 2023
    Fc-Engineered Anti-CTLA-4 Monoclonal Antibody Botensilimab in Advanced Cancer
  • 4 月 5, 2022
    NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
  • 4 月 5, 2022
    对转移性癌症患者施用经基因工程改造可表达对新抗原有反应的 T 细胞受体的自体 T 细胞
  • 4 月 5, 2022
    晚期或转移性实体瘤 NGM831 单药及与 Pembrolizumab 联合用药研究
  • 4 月 5, 2022
    表达 T 细胞受体 (TCR) 的自体 T 细胞对实体瘤受试者的 I/II 期研究
  • 4 月 5, 2022
    Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors